Business
Why the Bionomics (ASX:BNO) share price surged 8% higher today
The Bionomics Ltd (ASX: BNO) share price has run higher today after the company announced it has entered an agreement to licence its oncology drug candidate, BNC101, to Carina Biotech. At the market’s close, the Bionomics share price had surged 8.33% to 13 cents.
What’s pushing the Bionomics share price?
The Bionomics share price has marched higher today after the company advised that it will exclusively licence BNC101 to Carina. The agreement will see the development of Chimeric Antigen Receptor T-cell (CAR-T) therapy using Bionomics’ flagship drug. CAR-T is known to harness the body’s immune system to fight against cancer.
According to the company, BNC101 is a high-quality, humanised monoclonal antibody to LGR5, which…
-
Business24 hours agoshould I buy hedged or unhedged ASX US-focused ETFs?
-
Noosa News16 hours agoParents warned to be on alert as risk increases for Japanese Encephalitis this school holidays
-
Noosa News19 hours agoFound property, Kawana Waters – Sunshine Coast
-
Noosa News24 hours agoMaroochydore man, 49, dies in home ‘altercation’